Preventative and treatment effects of morinda citrifolia on diabetes and its related conditions

Abstract

The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

1 - 17 . (canceled)  
   
   
       18 . A method for treating and preventing diabetes comprising the steps of: 
 obtaining a naturaceutical formulation comprising a processed  Morinda citrifolia  product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    orally administering a safe, pre-determined amount of said naturaceutical formulation for safe, pre-determined frequency for a safe, pre-determined duration.    
   
   
       19 . The method of  claim 18 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       20 . The method of  claim 18 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       21 . The method of  claim 18 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       22 . The method of  claim 18 , wherein said processed  Morinda citrifolia  product comprises  Morinda citrifolia  fruit juice.  
   
   
       23 . The method of  claim 18 , wherein said processed  Morinda citrifolia  product comprises  Morinda citrifolia  puree juice.  
   
   
       24 . The method of  claim 18 , wherein said processed  Morinda citrifolia  product comprises  Morinda citrifolia  puree juice concentrate.  
   
   
       25 . The method of  claim 18 , further comprising the step of supplementing said step of orally administering said food product with a diabetes medication designed to treat diabetes and its associated conditions, said diabetes medication administered concurrently with said naturaceutical, wherein said naturaceutical increases the efficacy of said diabetes medication.  
   
   
       26 . The method of  claim 18 , wherein said safe, pre-determined amount is between about one teaspoon and about two ounces.  
   
   
       27 . The method of  claim 18 , wherein said safe, pre-determined frequency comprises at least two times per day on an empty stomach.  
   
   
       28 . The method of  claim 18 , wherein said safe, pre-determined duration of time comprises at least three consecutive days.  
   
   
       29 . The method of  claim 18 , wherein said naturaceutical is administered in an amount between about 1 teaspoon and 2 ounces at least twice daily on an empty stomach each day.  
   
   
       30 - 53 . (canceled)  
   
   
       54 . A method for balancing insulin output and glucose transfer, said method comprising the steps of: 
 introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  products, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.    
   
   
       55 . The method of  claim 54 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       56 . The method of  claim 54 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       57 . The method of  claim 54 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       58 . The method of  claim 54 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  fruit juice selected from dilute and concentrate form.  
   
   
       59 . The method of  claim 54 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  puree juice selected from dilute and concentrate form.  
   
   
       60 . The method of  claim 54 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  dietary fiber.  
   
   
       61 . A method for reducing the onset potential of diabetes, said method comprising the steps of: 
 introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.    
   
   
       62 . The method of  claim 61 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       63 . The method of  claim 61 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       64 . The method of  claim 61 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       65 . The method of  claim 61 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  fruit juice selected from dilute and concentrate form.  
   
   
       66 . The method of  claim 61 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  puree juice selected from dilute and concentrate form.  
   
   
       67 . The method of  claim 61 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  dietary fiber.  
   
   
       68 . A method for reducing glucose synthesis in the liver, said method comprising the steps of: 
 introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.    
   
   
       69 . The method of  claim 68 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       70 . The method of  claim 68 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       71 . The method of  claim 68 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       72 . The method of  claim 68 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  fruit juice selected from dilute and concentrate form.  
   
   
       73 . The method of  claim 68 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  puree juice selected from dilute and concentrate form.  
   
   
       74 . The method of  claim 68 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  dietary fiber.  
   
   
       75 . A method for accelerating glucose metabolism in the body of a mammal, said method comprising the steps of: 
 introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.    
   
   
       76 . The method of  claim 75 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       77 . The method of  claim 75 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       78 . The method of  claim 75 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       79 . The method of  claim 75 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  fruit juice selected from dilute and concentrate form.  
   
   
       80 . The method of  claim 75 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  puree juice selected from dilute and concentrate form.  
   
   
       81 . The method of  claim 75 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  dietary fiber.  
   
   
       82 . A method for inhibiting glucose absorption in the digestive tract of a mammal, said method comprising the steps of: 
 introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.    
   
   
       83 . The method of  claim 82 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       84 . The method of  claim 82 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       85 . The method of  claim 82 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       86 . The method of  claim 82 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  fruit juice selected from dilute and concentrate form.  
   
   
       87 . The method of  claim 82 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  puree juice selected from dilute and concentrate form.  
   
   
       88 . The method of  claim 82 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  dietary fiber.  
   
   
       89 . A method for improving glucose tolerance in the body of a mammal, said method comprising the steps of: 
 introducing, internally, a naturaceutical formulation into the body of a patient, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product, quercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight; and    administering safe, pre-determined doses of said naturaceutical formulation at safe, pre-determined frequencies and on a continual basis for a safe, pre-determined amount of time.    
   
   
       90 . The method of  claim 89 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf hot water extract  
   
   
       91 . The method of  claim 89 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf ethanol extract.  
   
   
       92 . The method of  claim 89 , wherein said processed  Morinda citrifolia  product comprises a processed  Morinda citrifolia  leaf steam distillation extract.  
   
   
       93 . The method of  claim 89 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  fruit juice selected from dilute and concentrate form.  
   
   
       94 . The method of  claim 89 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  puree juice selected from dilute and concentrate form.  
   
   
       95 . The method of  claim 89 , wherein said naturaceutical formulation further comprises processed  Morinda citrifolia  dietary fiber.  
   
   
       96 . A method for inhibiting the drug breakdown functions of cytochrome enzymes for the purpose of treating diabetes comprising the steps of: 
 administering a diabetes medication to a patient;    administering a naturaceutical to said patient concurrently with said diabetes medication, said naturaceutical comprising a processed  Morinda citrifolia  product, guercetin present in an amount between about 0.1 and 10 percent by weight and rutin present in an amount between about 0.1 and 10 percent by weight, that reduces and inhibits the breaking down or metabolizing of said diabetes medication by inhibiting the medication breakdown functions of said cytochrome enzymes, thus increasing the efficacy of said diabetes medication.